Partager cette page
Résultats de la première ronde de financement 2019-2022 du RCS : Accélération de la transposition clinique
| Chercheur principal | Cochercheurs et Collaborateurs | Titre du projet | Fonds du RCS octroyés |
|---|---|---|---|
| Zachary Laksman, University of British Columbia (UBC) | Gordon Keller (University Health Network) Glen Tibbits (UBC), Liam Brunham (UBC), David Vocadlo (Simon Fraser University), Francis Lynn (UBC), Lior Gepstein (Technion – Israel Institute of Technology), Patrick Boyle (University of Washington), Shubhayan Sanatani (BC Children’s Hospital Research Institute) | Pipeline Towards Stem Cell Driven Personalized Medicine for Atrial Fibrillation | 586 000 $ |
| Michael Laflamme, McEwen Stem Cell Institute, University Health Network (UHN) | Nilesh Ghugre (Sunnybrook Research Institute), Graham Wright (Sunnybrook Research Institute), Gordon Keller (UHN), Ren-Ke Li (UHN), Terrence Yau (UHN), Kumaraswamy Nanthakumar (UHN), Lior Gepstein (Technion – Israel Institute of Technology), Matthew Kay (George Washington University) | Heart Regeneration with Mature Ventricular Cardiomyocytes from Human Pluripotent Stem Cells | 599 685 $ |
| M. Cristina Nostro, McEwen Stem Cell Institute, University Health Network (UHN), University of Toronto | Greg Korbutt (University of Alberta), Andrew Pepper (University of Alberta), Esme Dijke (University of Alberta), James Shapiro (University of Alberta), Joanna Preston (TEC Edmonton), Atul Humar (UHN) | Co-localized hiPSC-derived Beta Cells and Immunosuppression-loaded Micelles as a Novel Approach for T1D Treatment | 600 000 $ |
| Bruce Verchere, University of British Columbia (UBC) | Francis Lynn (UBC), Megan Levings (UBC), Tim Kieffer (UBC), Dina Panagiotopoulos (UBC), Brad Hoffman (UBC), Greg Korbutt (University of Alberta) | Genetic Manipulation of hES-derived Insulin-producing Cells to Improve Graft Outcomes | 600 000 $ |
Résultats de la première ronde de financement 2019-2022 du RCS : Partenariats biotechnologiques
| Chercheur principal | Cochercheurs et Collaborateurs | Titre du projet | Fonds du RCS octroyés |
|---|---|---|---|
| Gilbert Bernier, Hôpital Maisonneuve-Rosemont (HMR), Université de Montréal (UMontréal) | May Griffith (HMR), Jean-François Bouchard (UMontréal), Stéphane Faubert (St-Hyacinthe Veterinary School), Cynthia Qian (HMR), Flavio Rezende (HMR) | Photoreceptor Transplantation for the Treatment of Retinal Degenerative Diseases | 500 000 $ |
| Tim Kieffer, University of British Columbia (UBC) | Corinne Hoesli (McGill University), James Piret (UBC), Megan Levings (UBC), Steven Paraskevas (The Research Institute of McGill University Health Centre), Richard Leask (McGill University), Patrick MacDonald (University of Alberta) | A Bioprinted Insulin-Producing Device for Diabetes | 500 000 $ |
| Massimiliano Paganelli (CHU-Sainte-Justine, Université de Montréal (UMontréal) | Christopher Rose (UMontréal), Michel Lallier (CHU-Sainte-Justine), Constantine Karvellas (University of Alberta), Siofradh McMahon (CCRM) | iPSC-derived Encapsulated Liver Tissue to Treat Acute Liver Failure: Pivotal Confirmation in Large Animals | 500 000 $ |
Résultats de la première ronde de financement 2019-2022 du RCS : Avancement des essais cliniques
| Chercheur principal | Cochercheurs et Collaborateurs | Titre du projet | Fonds du RCS octroyés |
|---|---|---|---|
| Sandra Cohen, Hôpital Maisonneuve-Rosemont (HMR), Université de Montréal (UMontréal) | Jean-Sébastien Delisle (HMR), Gizelle Popradi (McGill University Hospital Center), Frédéric Barabé (Centre de recherche CHU de Québec-Université Laval), Nadia Bambace (HMR), Léa Bernard (HMR), Guy Sauvageau (UMontréal), Josée Hébert (UMontréal), Filippo Milano (Fred Hutchinson Cancer Research Center), Peter Zandstra (University of British Columbia), Sébastien Lemieux (UMontréal), Gabriel Tremblay (Purple Squirrel Economics), Lambert Busque (HMR), Denis-Claude Roy (HMR) | UM171-Expanded Cord Blood Grafts Offer Potential Cure for Very High-Risk Leukemia Patients | 1 000 000 $ |
| Lucie Germain, Université Laval (ULaval) | François A. Auger (ULaval), Bartha M. Knoppers (McGill University), Richard Bazin (ULaval), Isabelle Brunette (UMontréal), Allan Slomovic (Toronto Western Hospital), Mohib Morcos (McGill University), Michel Ouellet (Patient representative), Charles Giguère (Centre de recherche de l'Institut universitaire en santé mentale de Montréal) | Cultured Epithelial Corneal Autografts for the Treatment of Canadians with Limbal Stem Cell Deficiency | 500 000 $ |
| Véronique Moulin, Université Laval (ULaval) | François A. Auger (ULaval), Lucie Germain (ULaval), Bartha M. Knoppers (McGill University), Isabelle Perreault (CHU-Sainte-Justine), Sarvesh Logsetty (Winnipeg Burn Unit), Ariane Bussière (Québec Burn Unit), Patricia Bortoluzzi (CHU-Sainte-Justine), Vince Gabriel (Calgary Firefighter Burn Treatment Centre), Duncan Nickerson (Calgary Firefighter Burn Treatment Centre), Sally Hynes (BC Children’s Hospital Research Institute), Edward Tredget (Walter C. Mackenzie Health Sciences Centre), Josh Wong (Walter C. Mackenzie Health Sciences Centre), Peter Kwan (Walter C. Mackenzie Health Sciences Centre), Joel Fish (The Hospital for Sick Children), Claudia Malik (Children’s Hospital of Eastern Ontario), Marc Jeschke (Sunnybrook Research Institute), Sue-Ling Chang (Patient representative) | Self-Assembly Skin Substitutes (SASS) for the Treatment of Acute Wounds of Canadian Burn Patients | 470 645 $ |
| Bernard Thébaud, Ottawa Hospital Research Institute (OHRI), University of Ottawa (UOttawa), Children’s Hospital of Eastern Ontario (CHEO) | Dean Fergusson (OHRI), Justin Presseau (UOttawa), Kednapa Thavorn (UOttawa), Brigitte Lemyre (CHEO), Mario Ruediger (Technische Universität Dresden), Nadya Ben Fadel (CHEO), Robert Jankov (CHEO), Jana Feberova (CHEO), David Courtman (OHRI) | HULC-I: Helping Underdeveloped Lungs with Mesenchymal Stromal Cells – A phase I Trial | 638 150 $ |
Résultats de la première ronde de financement 2019-2022 du RCS : Application et société
| Chercheur principal | Cochercheurs et Collaborateurs | Titre du projet | Fonds du RCS octroyés |
|---|---|---|---|
| Bartha M. Knoppers, McGill University | Christine Bear (The Hospital for Sick Children), Felix Ratjen (The Hospital for Sick Children), Amy Wong (The Hospital for Sick Children), Paul Eckford (The Hospital for Sick Children), Elizabeth Stephenson (The Hospital for Sick Children), Michael Szego (University of Toronto), Julie Fradette (Université Laval), Mark Rothstein (University of Louisville School of Medicine) | Ethical and Legal Framework for Direct-to-Participant (DTP) Recruitment | 75 000 $ |
Résultats de la première ronde de financement 2019-2022 du RCS : Recherche innovante
| Chercheur principal | Cochercheurs et Collaborateurs | Titre du projet | Fonds du RCS octroyés |
|---|---|---|---|
| Florian Bentzinger, Université de Sherbrooke (USherbrooke) | Eric Marsault (USherbrooke), Penney Gilbert (University of Toronto), Mannix Auger-Messier (USherbrooke), Ubaka Ogbogu (University of Alberta), Jerome Feige (Nestlé Research), Nicolas Dumont (CHU-Sainte-Justine), Alison McGuigan (University of Toronto) | Targeting Endogenous Repair: A Novel Mutation Independent Pharmacological Approach for Treatment of Muscular Dystrophy | 330 000 $ |
Sommaire du résultats de la première ronde de financement 2019-2022 du RCS
| Demandes reçues | Demandes dont l’acceptation recommandée | Pourcentage d’acceptation des demandes | Investissement total |
|---|---|---|---|
| 37 | 13 | 35% | 6,9 M$ |
* Les titres des projets sont affichés selon la langue de soumission